Gentex Corporation - Common Stock (GNTX)
22.67
-0.85 (-3.64%)
NASDAQ · Last Trade: Apr 3rd, 10:50 AM EDT

Analyzing GENTEX CORP (NASDAQ:GNTX)'s Dividend Potential.
Via Chartmill · March 5, 2025

A look at 15 consumer discretionary stocks that look reasonably valued.
Via Talk Markets · November 14, 2024

Is GENTEX CORP (NASDAQ:GNTX) suited for dividend investing?
Via Chartmill · May 22, 2024

Gentex Corporation's Q3 earnings beat estimates with a 53-cent EPS and $608.53 million in revenue, driving stock gain.
Via Benzinga · October 25, 2024

Viking Therapeutics received an Overweight rating and a December 2025 price target of $80 from JPMorgan analysts.
Via Benzinga · September 20, 2024

VOXX International stock is trading higher Tuesday following the company's announcement that it is considering a sale of the company.
Via Benzinga · August 27, 2024
We’ve seen largely overbought conditions accompanied by sub-optimal setups and a general lack of tidiness. Then you get an unforeseeable catalyst that shakes everything up.
Via Talk Markets · July 29, 2024

GNTX stock results show that Gentex missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via InvestorPlace · July 26, 2024

Via Benzinga · October 18, 2023

Indications Suggest NASDAQ:GNTX Could Be on the Verge of a Breakout.
Via Chartmill · October 3, 2023

Gentex shares tumble after missing Q2 earnings estimates and cutting its FY24 revenue forecast.
Via Benzinga · July 26, 2024

Before investors get too excited about what appears to be a cheap P/E valuation for Adient's stock, they may want to pay attention to the trend of declining earnings estimate revisions.
Via Talk Markets · June 18, 2024

GNTX stock results show that Gentex met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via InvestorPlace · April 26, 2024

The double-digit growth of these three consumer stocks is an excellent indicator of long-term returns. Buy them now.
Via InvestorPlace · February 15, 2024

Gentex Corp (NASDAQ: GNTX) gains as it zooms past Q4 expectations, with sales hitting $589.1 million and EPS at $0.50, surpassing analyst estimates. Gentex projects FY24 revenues of $2.45 billion - $2.55 billion, building a roadmap for achieving a 35% - 36% gross margin by year-end.
Via Benzinga · January 26, 2024

U.S. stocks traded mixed, with the Dow Jones gaining around 80 points on Friday.
Via Benzinga · January 26, 2024

Companies Reporting Before The Bell • Autoliv (NYSE:ALV) is projected to report quarterly earnings at $3.23 per share on revenue of $2.75 billion.
Via Benzinga · January 26, 2024

Electro-optical products supplier Gentex Corporation (NASDAQ: GNTX) has entered into a partnership agreement with wireless power transfer technology company Solace Power.
Via Benzinga · January 8, 2024

Gentex Corporation (NASDAQ: GNTX) reported third-quarter FY23 sales growth of 17% year-on-year to $575.85 million, beating the analyst consensus of $566.22 million.
Via Benzinga · October 27, 2023

Companies Reporting Before The Bell • Sanofi (NASDAQ:SNY) is projected to report quarterly earnings at $2.26 per share on revenue of $12.56 billion.
Via Benzinga · October 27, 2023